Literature DB >> 412965

Potential inhibitors of collagen biosynthesis. 5,5-Difluoro-DL-lysine and 5,5-dimethyl-DL-lysine and their activation by lysyl-tRNA ligase.

F N Shirota, H T Nagasawa, J A Elberling.   

Abstract

The synthesis of lysine analogues wherein blocking groups are substituted at position 5, the site of hydroxylation by peptidyl lysine hydroxylase, is described. Thus, 5,5-difluorolysine (1) and 5,5-dimethylysine (2) were synthesized via a four- and six-step sequence, respectively, starting from ketone precursors. The propensity for these lysine analogues to be incorporated into procollagen protein in vivo was assessed by their ability to stimulate the lysine-dependent ATP-PPi exchange reaction in the presence of lysyl-tRNA ligase in vitro. The difluoro analogue 1 stimulated exchange, but at a Km (1.3 X 10(-3) M) 1000 times greater than that for lysine itself. The dimethyl analogue 2 did not stimulate exchange, but at high concentrations was a competitive inhibitor of lysine, with an apparent Ki of 1.6 X 10(-2) M. Thus, electronegative and/or bulky substituents at the 5 position of lysine cannot be tolerated by lysyl-tRNA ligase, and this position must be kept free in lysine analogues specifically designed to block collagen biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 412965     DOI: 10.1021/jm00222a017

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  Stabilization of collagen-model, triple-helical peptides for in vitro and in vivo applications.

Authors:  Manishabrata Bhowmick; Gregg B Fields
Journal:  Methods Mol Biol       Date:  2013

2.  Syntheses of fluorinated amino acids: from the classical to the modern concept.

Authors:  V Tolman
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

Review 3.  Exploitation of folate and antifolate polyglutamylation to achieve selective anticancer chemotherapy.

Authors:  J J McGuire; T Tsukamoto; B P Hart; J K Coward; T I Kalman; J Galivan
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.